Search Results - "GAGLIA, Michael A"

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis by Lipinski, Michael J, Escarcega, Ricardo O, Baker, Nevin C, Benn, Hadiya A, Gaglia, Jr, Michael A, Torguson, Rebecca, Waksman, Ron

“…The aim of this study was to determine the risk of scaffold thrombosis (ST) after percutaneous coronary intervention (PCI) with placement of an ABSORB…”
Get full text

Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients by Ben-Dor, Itsik, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Goldstein, Steven A., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Weissman, Gaby, MD, Maluenda, Gabriel, MD, Gonzalez, Manuel A., MD, MPH, Wakabayashi, Kohei, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Xue, Zhenyi, MS, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Objectives This study aimed to determine the success, complications, and survival of patients after balloon aortic valvuloplasty (BAV). Background The…”
Get full text

Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelor by Gaglia, Jr, Michael A, Waksman, Ron

Get full text

Clinical Profile, Prognostic Implication, and Response to Treatment of Pulmonary Hypertension in Patients With Severe Aortic Stenosis by Ben-Dor, Itsik, MD, Goldstein, Steven A., MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Maluenda, Gabriel, MD, Li, Yanlin, MD, Syed, Asmir I., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Wakabayashi, Kohei, MD, Delhaye, Cedric, MD, Belle, Loic, MD, Wang, Zuyue, MD, Collins, Sara D., MD, Torguson, Rebecca, MPH, Okubagzi, Petros, MD, Aderotoye, Adefolaseyi, MS, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Epstein, Stephen E., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The incidence, correlates, and prognostic implications of pulmonary hypertension (PH) are unclear in patients with severe aortic stenosis (AS). We studied 509…”
Get full text

Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With Ticagrelor by Gaglia, Michael A., Lipinski, Michael J., Lhermusier, Thibault, Steinvil, Arie, Kiramijyan, Sarkis, Pokharel, Shreejana, Torguson, Rebecca, Angiolillo, Dominick J., Wallentin, Lars, Storey, Robert F., Waksman, Ron

“…Ticagrelor, a potent platelet inhibitor, has primarily been studied in white patients. Platelet reactivity among black patients with acute coronary syndrome…”
Get full text

Ticagrelor and the prevention of cardiovascular mortality: more than just platelet inhibition? by Gaglia, Jr, Michael A

Get more information

Cerebrovascular accidents after percutaneous coronary interventions from 2002 to 2014: Incidence, outcomes, and associated variables by Didier, Romain, MD, Gaglia, Michael A., MD, MSc, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita I., MD, Omar, Al Fazir, MD, Gai, Jiaxing, MSPH, Torguson, Rebecca, MPH, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Cerebrovascular accident (CVA) and transient ischemic attack (TIA) related to percutaneous coronary intervention (PCI) are relatively rare…”
Get full text

Frequency of Angina Pectoris After Percutaneous Coronary Intervention and the Effect of Metallic Stent Type by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Lipinski, Michael J., MD, PhD, Gai, Jiaxiang, MSPH, Koifman, Edward, MD, Kiramijyan, Sarkis, MD, Negi, Smita, MD, Rogers, Toby, MD, Steinvil, Arie, MD, Suddath, William O., MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Although metallic coronary stents significantly reduce angina pectoris compared with optimal medical therapy, angina after percutaneous coronary intervention…”
Get full text

Effect of marital status on the outcome of patients undergoing elective or urgent coronary revascularization by Barbash, Israel M., MD, Gaglia, Michael A., MD, Torguson, Rebecca, MPH, Minha, Sa'ar, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Marriage confers various health advantages in the general population. However, the added value of marriage among patients who undergo percutaneous…”
Get full text

Relation of Proton Pump Inhibitor Use After Percutaneous Coronary Intervention With Drug-Eluting Stents to Outcomes by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Hanna, Nicholas, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Recent evidence has shown that clopidogrel and proton pump inhibitors (PPIs) are metabolized by the same pathway and that patients taking both drugs have…”
Get full text

Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents by Steinberg, Daniel H., MD, Gaglia, Michael A., MD, MSc, Pinto Slottow, Tina L., MD, Roy, Probal, MD, Bonello, Laurent, MD, De Labriolle, Axel, MD, Lemesle, Gilles, MD, Torguson, Rebecca, MPH, Kineshige, Kimberly, BS, Xue, Zhenyi, MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Drug-eluting stent (DES) implantation is the standard treatment for patients with bare-metal stent (BMS) in-stent restenosis (ISR) and is associated with low…”
Get full text

Impact of Baseline Mitral Regurgitation on Short- and Long-Term Outcomes Following Transcatheter Aortic Valve Replacement by Kiramijyan, Sarkis, MD, Magalhaes, Marco A., MD, Koifman, Edward, MD, Didier, Romain, MD, Escarcega, Ricardo O., MD, Minha, Sa’ar, MD, Baker, Nevin C., DO, Negi, Smita I., MD, Torguson, Rebecca, MPH, Gai, Jiaxiang, MSPH, Okubagzi, Petros, MD, Asch, Federico M., MD, Gaglia, Michael A., MD, Ben-Dor, Itsik, MD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Abstract Background The prevalence of concomitant significant mitral regurgitation (MR) in patients with severe aortic stenosis undergoing transcatheter aortic…”
Get full text

Warfarin Prophylaxis for Anterior Infarction: Another Black Mark for Triple Therapy by Gaglia, Michael A.

Get full text

Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction by Wakabayashi, Kohei, MD, Gonzalez, Manuel A., MD, MPH, Delhaye, Cedric, MD, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Several reports have alluded to the adverse effect of chronic obstructive pulmonary disease (COPD) on long-term prognosis of patients with myocardial…”
Get full text

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era? by COLLINS, Sara D, TORGUSON, Rebecca, KENT, Kenneth M, PICHARD, Augusto D, SUDDATH, William O, SATLER, Lowell F, WAKSMAN, Ron, GAGLIA, Michael A, LEMESLE, Gilles, SYED, Asmir I, BEN-DOR, Itsik, YANLIN LI, MALUENDA, Gabriel, KANESHIGE, Kimberly, ZHENYI XUE

“…It has been suggested that black race predicts stent thrombosis (ST) after drug-eluting stent implantation. Whether socioeconomic status or comorbid conditions…”
Get full text

Correlates and Causes of Death in Patients With Severe Symptomatic Aortic Stenosis Who Are Not Eligible to Participate in a Clinical Trial of Transcatheter Aortic Valve Implantation by BEN-DOR, Itsik, PICHARD, Augusto D, DELHAYE, Cedric, WAKABAYASHI, Kohei, GAGLIA, Michael A, TORGUSON, Rebecca, ZHENYI XUE, SATLER, Lowell F, SUDDATH, William O, KENT, Kenneth M, LINDSAY, Joseph, WAKSMAN, Ron, GONZALEZ, Manuel A, WEISSMAN, Gaby, YANLIN LI, GOLDSTEIN, Steven A, OKUBAGZI, Petros, SYED, Asmir I, MALUENDA, Gabriel, COLLINS, Sara D

“…Transcatheter aortic valve implantation is currently being evaluated in patients with severe aortic stenosis who are considered high-risk surgical candidates…”
Get full text

Correlation between fractional flow reserve and intravascular ultrasound lumen area in intermediate coronary artery stenosis by BEN-DOR, Itsik, TORGUSON, Rebecca, PICHARD, Augusto D, WAKSMAN, Ron, GAGLIA, Michael A, GONZALEZ, Manuel A, MALUENDA, Gabriel, BUI, Anh B, ZHENYI XUE, SATLER, Lowell F, SUDDATH, William O, LINDSAY, Joseph

“…Fractional flow reserve (FFR) of <0.8 or 0.75 is currently used to guide revascularisation in lesions with intermediate coronary stenosis. We assessed whether…”
Get full text

Comparison in Men Versus Women of Co-morbidities, Complications, and Outcomes After Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis by Gaglia, Michael A., Lipinski, Michael J., Torguson, Rebecca, Gai, Jiaxiang, Ben-Dor, Itsik, Bernardo, Nelson L., Satler, Lowell F., Pichard, Augusto D., Waksman, Ron

“…Transcatheter aortic valve implantation (TAVI) decreases mortality in high-risk patients with severe aortic stenosis, but it remains unclear if female gender…”
Get full text

Retroperitoneal hemorrhage after percutaneous coronary intervention in the current practice era: Clinical outcomes and prognostic value of abdominal/pelvic computed tomography by Maluenda, Gabriel, Mitulescu, Lavinia, Ben-Dor, Itsik, A. Gaglia Jr, Michael, Weissman, Gaby, Torguson, Rebecca, F. Satler, Lowell, Pichard, Augusto D., Bernardo, Nelson L., Waksman, Ron

“…Background: Retroperitoneal hemorrhage (RPH) is a serious but infrequent complication of percutaneous coronary intervention (PCI). This study aimed to describe…”
Get full text

Antiplatelet therapy for peripheral arterial disease and critical limb ischemia: guidelines abound, but where are the data? by Azarbal, Amir, Clavijo, Leonardo, Gaglia, Jr, Michael A

“…Antiplatelet therapy is invariably prescribed for patients with peripheral arterial disease and critical limb ischemia, and numerous major society guidelines…”
Get more information